Try our Advanced Search for more refined results
Life Sciences - August, 2013
289 articles
- Arthrex Infringed Rival's Suture Patents, Calif. Jury Says
- Biolitec Escapes Additional Sanctions In AngioDynamics Row
- Genzyme, Sanofi Take Aim At Generic Cancer Drug
- Calif. County's Drug Disposal Mandate Found Constitutional
- PhRMA Urges Fed. Circ. To Rethink Novo Patent Obviousness
- Fosamax MDL To Wind Down More Swiftly Than Merck Wanted
- J&J Faces Contempt For Contacting Glucose-Strip Sellers
- Infant Incubator Maker Slaps Japanese Co. With ITC Suit
- Smith & Nephew Seeks To Ax Doc's Suit Over Device Training
- Meda Scoops Up Asthma Inhaler Maker For $135M
- Key Issues In Handling Product Recalls
- 5 Tips For In-House Counsel Handling Gov't Inquiries
- Everett Can't Bar Acella From Linking Vitamins In Databases
- Imported Food For Thought: FDA On Foreign Food Safety
- Onyx Targeted In Shareholder Suit Over $10.4B Amgen Deal
- FDA Sounds Alarm Over State Biosimilar Drugs Bills
- HHS Slams Ex-InterMune CEO's Challenge To Program Ban
- Disbarred Fen-Phen Attys Take $42M Hit In Ky. High Court
- Takeda Sues Mylan Over Generic Acid Reflux Drug
- Special Masters Back Atty Fee Bid In $688M Vytorin Deal
- Proxy Firms Recommend $9B Actavis-Warner Chilcott Deal
- Bankrupt K-V To Pay $24M To Settle FCA Suit
- NuVasive Medicare Investigation Spurs Securities Class Action
- FDA Concerns Over Testing Co. Trigger Compounder Recalls
- Horizon Pharma Targets Actavis Over Generic Rayos
- Public Citizen Wants HHS To Stop Trials Over Consent Issue
- 10th Circ. Backs Wyeth, Schwarz Win in Generic Reglan Suit
- MDL Panel Combines Diabetes Drug Cancer Suits
- K-V Pharma Judge Greenlights Reorganization Plan
- Endo Health To Pay $225M For Generics Company
- Cleary Seals $495M Simcere Sale To Founder, Partners
- DePuy Hip Implant Attys Call For FDA Investigation
- CMS Plans Further Crackdown On Test-Strip Billing
- Alcon Dodges FCA Suit Over Eye Drug Marketing
- Kohlberg Picks Up Calif. Nutritional Supplements Co.
- Biolitec Loses Bid To DQ Judge In AngioDynamics Row
- Hepatitis B Patent Ruling 'Infected,' BMS Tells Fed. Circ.
- Covidien's Surgical Seal Patent Win Upheld By Fed. Circ.
- 'Good Lab Practices' Don't Apply To Early Device Work: FDA
- Myriad Says It's Immune From Ambry's Antitrust Claims
- NJ Court Nixes Trade Secrets Row Over Generic Cough Syrup
- FDA Details Ethics Panel Duties In Clinical Trials
- Fresenius Hid 'Serious' Health Risks Of GranuFlo, Suit Says
- Amgen's $10B Onyx Buy Takes Training Wheels Off 251(h)
- IP Firm Shakes Supplement Co.'s $4M Malpractice Suit
- Novartis Can't Rush Appeal In Elidel FCA Suit, Judge Says
- Kirkland, Polsinelli Rep Akorn In $640M Hi-Tech Pharma Buy
- How To Counter Product Counterfeiting
- Mylan Says Cephalon's IP Win Based On Wrong Construction
- Nestle Sues RenaGum Maker Over Kidney Disease Treatment
- Peregrine Beats Shareholder Suit Over Lung Cancer Drug
- FDA Details Shelf-Life Testing For Generic Drugs
- Novo Wants High Court To Clarify Foreign Company Liability
- FDA Scolds Drugmakers For Missing Pediatric Study Deadlines
- Covington Reps AstraZeneca In $500M Amplimmune Buy
- Lost Opportunities: Why Cases Settle At The Wrong Time
- Amgen Bags Onyx For $10.4B After Quick Chase
- How They Won It: Fish Nixes $23M Baxter Win With Re-Exam
- Fed. Circ. Affirms Histogen Win In Skin Care IP Suit
- Medtronic Can't Duck Injury Suit Over Bone Graft Device
- Pfizer Settles Former Exec's FCA Suit In 1st Circ.
- Iovate Supplements Don't Build Muscle As Advertised: Suit
- Depomed Says It Was Cheated Out Of Orphan Drug Exclusivity
- FDA Warns Fresenius After Puerto Rico Plant Inspection
- McCarter Further Expands IP Practice With 2 New Hires
- Novartis Sues Par Over Dementia Patch Generic
- Deals Rumor Mill: Amgen, Panasonic, Direct Edge
- Green Light For More Deceptive Labeling Class Actions
- Rainmaker Q&A: Ballard Spahr's Stephen Kastenberg
- Picture This — FDA Taking Inspection Photos
- Who Gives A Sheet About Graphene?
- Biomet's Preemption Bid Fails In Metal Hip Implant MDL
- Stryker Unit Settles OT Miscalculation Collective Action
- Abbott Can't Wipe Out $2.2M Verdict In Humira Case
- Merck Can't Force Fosamax Plaintiffs To Verify Injuries
- Salix Did Its Part In Developing Napo Drug, Atty Argues
- AbbVie Asks Fed. Circ. To Revive Antibody Patent Suit
- Purdue Sues TWi Over Insomnia Drug Generic Plans
- St. Jude, Volcano Can't Flip Heart Device IP Verdicts
- Jones Day Adds Life Sciences, Tech M&A Partner In Atlanta
- ACLU, Others Blast Myriad Bid To Halt Rival Gene Tests
- Deals Rumor Mill: HP, Sharp, KKR
- Sanofi Settles Inflammation-Drug Kickback Claims
- Bard Settles 2nd Vaginal Mesh Bellwether On Trial's 1st Day
- Patient Groups Decry ACA Medicaid Drug Coverage Rule
- OTC Drug Group Wants Children's Dosage On Med Labels
- A-Rod's Cousin Gets Deposition Delayed In MLB Drug Suit
- Reckitt Sues To Block Par's Generic Suboxone
- 3rd Circ. Takes Ascertainability More Seriously
- Watchdog Urges FDA To Put 'Black Box' Warning On Plavix
- FDA Finds Drug Co. Clinical Tests Lack Diversity
- Mallinckrodt Breached Pain Med Licensing Deal, Nuvo Says
- Expanding Miles & Stockbridge Nabs 7 From Baker Donelson
- Sandoz Wants Rapaflo Infringement Suit Trimmed
- Law Firms' Intervention Bid Nixed In GSK Class Action
- Ackman Says Regulators Eyeing Herbalife, Sticks To $1B Short
- Allergan Demands FDA Retract Generic Restasis Guidance
- Deals Rumor Mill: TPG, Blackstone, AIG
- 6th Circ. Took A Wrong Turn In Omnicare Case
- Trio Of Favorable Preemption Decisions For NJ Pharma Cos.
- Rainmaker Q&A: Sterne Kessler's Robert Sterne
- Dumpster Diving For Deleted Files: When Is It Worth It?
- Eisai's Attacks Pressure Feds To Patch Exclusivity Holes
- Bayer Wants Out Of Probiotic False Ad Class Action
- Texas Panel Quashes $10M Judgments Against Fen-Phen Atty
- FDA Links Foreign Drugs To Life-Threatening Side Effects
- Shire Billed Medicaid For Off-Label ADHD Drug Use, La. Says
- Rainmaker Q&A: Ulmer & Berne's Michael Switzer
- Stryker Says Junk-Fax Class Action Would Hurt Doctors
- Crisis Mismanagement And Other Cautionary Tales
- New FDA Drug Security Program Targets Dubious Imports
- PE Activity Is Increasing In The Urgent Care Space
- FDA Warns Drug Ingredient Maker Over Testing Issues
- How Fed. Circ. May View Post-AIA Invention Sales Offers
- Russian Antitrust Watchdog Warns Teva Over MS Drug
- Okla. Judge Halts State Plan B Restrictions
- Icahn Rips Investor's Bid To Bar Potential Herbalife Deal
- Brookstone Beats 'Generic' Acne Gel False Ad Suit In 11th Circ.
- Merck, Plaintiffs Bicker Over Fosamax MDL Wind-Down Plans
- Eisai Slams DEA Over Delay In Scheduling Seizure Med
- Gibson Dunn, Homburger Aid St. Jude's $170M Endosense Buy
- Orthofix Flooded With Investor Suits Over Restated Earnings
- ITC Launches New Patent Probe Of Sleep Aid Devices
- Becton Can't Dodge Rival Syringe Maker's Antitrust Claims
- 3rd Circ. Revives Device Co. Recoupment Suit Against Aetna
- Hospira Can't Shake Ex-USC Player's Pain Med Claims
- Medical Supplier Hits Ch. 11 Planning $22M Sale
- Atty Should Forfeit $5M From NFLer's Stock Scheme, US Says
- K-V Creditors Slam Senior Bondholders' Bid For Interest
- Investor Sues RyMed Directors Over Loan Default
- Teva Sues Perrigo Over ProAir Generic Plans
- Rainmaker Q&A: Fish & Richardson's Juanita Brooks
- Weil Guides Bard In $200M Deal For Hemostat Maker Medafor
- Agave BioSystems Settles FCA Claims Over Contract Staffing
- A Win For Prop 65 Defendants, Lessons For All
- Windsor Proves Court Erred In Booting Gay Juror, GSK Says
- Shire Wins Dismissal Of Generic Adderall Antitrust Suit
- US Backs Medtronic In High Court Burden-Of-Proof Case
- No Mass Tort For Tylenol Liver Cases In NJ
- Roche Asks NJ High Court To Kick Judge Off Accutane Suits
- FTC Wants To Extend Actavis To Authorized Generics Deals
- Drug Co.'s Readmissions Work Survives Kickback Scrutiny
- Health Plans Sue Abbott Over Depakote Off-Label Scheme
- 7th Circ. Revives Baxter Investor Suit Over $588M Recall
- FDA Awareness Letters Have Impact, Allergan Counsel Says
- Rainmaker Q&A: Sterne Kessler's Eric Steffe
- Sekisui Sanctioned For Email Deletion In Merger Fight
- Cardinal Health Suit Lacked Pre-Suit Demand, 6th Circ. Says
- Labeling Update Claims Survive Dismissal In Fosamax MDL
- Bard Hit With $2M Verdict In Vaginal Mesh Bellwether
- Rivals Fight Myriad Bid For Gene Test Ban In Patent Case
- Merck, Plaintiffs Fail To Reach Deal In Fosamax Jaw MDL
- Antibiotic Type Poses Severe Nerve Damage Risk, FDA Says
- Novo Nordisk Sues Amneal Over Vagifem Generic
- UnitedHealth Slams Law Firms' Intervention Bid In GSK Action
- Univ. Of Wis. Defends Stem Cell Patent At Fed. Circ.
- Deals Rumor Mill: Amgen, Newfield, Verizon
- Homeopathic Drugmaker Puts Up $1M To End False Ad Claims
- Galderma Fights Appeal Fee Bid In NYU Oracea Dispute
- Rainmaker Q&A: Choate Hall's Paul Popeo
- Calif. Gov. Vetoes Bill Allowing Payment For Egg Donations
- Siemens Gets Fresh Shot At HIV Test Patent
- Novartis Opens Probe Into Whistleblower's Kickback Claims
- J&J, DePuy Fail To Split Up Consolidated Hip Implant Trial
- FDA Knew Compounder Had Unsterile Practices: Watchdog
- The Cost, And Ethics, Of Doing (Legal) Business
- FCA's Reach At Stake As DOJ Jumps Into 1st Circ. Fight
- Doc Access Deal OK'd In SAC Insider Trading Class Action
- Avanir Settles With Sandoz Over Nuedexta Generic Plans
- Watson Pays $8.5M To Resolve Medicaid Fraud Claims
- Gray Zone Between FDA And FTC Nutraceutical Regulation
- Investors In Dissolved Biotech Co. Sued Too Late, Judge Rules
- FDA Outlines Safety Testing For Telehealth Medical Devices
- Medical Foods Don't Require A Prescription, FDA Says
- Pharmstandard To Pay $590M For Pharmaceutical Supply Co.
- Gilead, Roche Settle Ranexa Patent Suit Against Lupin
- Kaye Scholer Snags Pepper Hamilton Antitrust Partner
- Acne Drug Licensing Suit Allowed To Stay In Court
- Sheppard Mullin Adds Finance, Patent Pros In Bay Area
- FDA Accused Of Cutting Obesity Drug's Exclusivity Short
- Deals Rumor Mill: Blackstone, Onyx, Steinway
- Rainmaker Q&A: Wolf Greenfield's Edward Gates
- $818M Deal Lowballs Trius On Brink Of Drug Launch, Suit Says
- Fed. Circ. Revives Leo Psoriasis Drug Patent
- Novel Labs Asks Fed Circ. For Reversal In Suprep Suit
- GSK Triumphs In Avodart Patent Challenge
- Merck Wants Fosamax Plaintiffs To Cough Up Evidence
- Mylan Ducks $15M Bristol-Myers Contract Suit Over HIV Drug
- AstraZeneca Defends Pulmicort Patents At Fed. Circ.
- Eyeing Antibiotics, Drugmakers Ask For Longer Pathogen List
- Columbia Labs Slams Investor Suit Over Rejected Drug
- ACA Push For Cost-Effective Care Spurs $200M Medtronic Buy
- Fed. Circ. Won't Review Invalidity Ruling Over Yaz Patent
- Sanofi Faces China Bribery Probe Over Whistleblower Claims
- Compounding Pharmacy Linked To Infections Issues Recall
- Pa.'s Series Of Pharma Cases Give RLD Theory Some Legs
- Vital Shakes False Ad Suit Over Fat Loss Supplement
- Allergan Eye Antibiotic Patent Claims Ruled Invalid
- With Stark Law Loophole Under Fire, Docs Eye Bottom Line
- Depomed Sues Banner, Watson Over Proposed Generic Zipsor
- Ulmer & Berne Nabs Skadden Litigation Pro In Chicago
- FDA Links 15 Infections To Texas Compounding Pharmacy
- Fed. Circ. Backs Sequenom Bid To Bar Ariosa Prenatal Test
- Axis Scores Docs In D&O Coverage Fight With BioChemics
- Judge Knocks Bellwether Pool In Boston Scientific Mesh MDL
- Deals Rumor Mill: BlackBerry, Smithfield, Amgen
- Supplement Maker Can't Shake Glucosamine False Ad Action
- FDA Won't Approve Wright Medical Bone Graft Application
- GlaxoSmithKline Launches $50M Biotech Venture Fund
- India Nixes Patents For Allergan Glaucoma Drugs
- More Wiggle Room In Gluten-Free Labeling
- USPTO Re-Exam Considerations After Fresenius V. Baxter
- Fraud Claims Escape Preemption In Medtronic Bone Graft Suit
- Shire Urges Fed. Circ. To Block Actavis' Generic Lialda
- Supernus Sues Actavis, Watson Over Oxtellar XR Patents
- Judge To Review Cephalon Docs In FTC Pay-For-Delay Row
- Wyeth To Pay $14M In Attys' Fees In Pristiq Class Action
- Pfizer Can't Escape Neurontin Antitrust MDL
- Rainmaker Q&A: Seyfarth's Gerald Maatman
- PSS Says Ex-Workers Took Trade Secrets, Clients To New Co.
- Compounder Wins Transfer Of Eye Injury Suits To La.
- FDA Faces Dueling Demands On Antibiotic Clinical Trials
- Chinese Authorities Probe Danish Drug Cos. Amid GSK Fallout
- Pharmavite Ducks Class Cert. In Vitamin Supplement Suit
- How FDA's Adverse Event Reporting System Impacts Drug Cos.
- DaVita Seeks To Toss Dialysis Products Class Action
- Stryker Wins $210M In Device Patent Suit Against Zimmer
- TPG Looking To Sell Canadian Drugmaker For $3B
- Whistleblowers Rip Boston Scientific's Bid To Bar Evidence
- GNC Supplements Do Not Increase Blood Flow, Suit Says
- SAC Trader Accused Of Obstruction In $276M Investor Suit
- Fed. Circ. Revives Galderma's Patents On Rosacea Drug
- Medical Co. Hit With Investor Suit Over $20M Sham Financing
- FDA Ordered To Turn Over Docs In Truvada FOIA Suit
- Vinson & Elkins Lures Ex-Hogan Lovells Partner To SF Office
- Deals Rumor Mill: Amgen, Wal-Mart, Cinven
- Fed. Circ. Affirms J&J Contact Lens Patent Victory
- Walgreen Can't Duck Supplement False Ad Suit
- AstraZeneca Can't Duck Patent Claim Over Symbicort Inhaler
- Clinical Trial Oversight Must Focus On Major Risks, FDA Says
- JPML Consolidates Effexor Birth Defect Actions In Pa.
- Shareholder Urges Taro To Side With Activist's Board Picks
- Cobalis Suit Over Hedge Fund Scheme Tossed In NJ
- Global Patchwork Of Bribery Laws Complicates GSK Defense
- Vision Pharma Seeks $3M From Sunrise For Adulterated Drugs
- Andrx Can't Beat AstraZeneca's Prilosec Patent Suit
- Hedge Fund Can Seek Digirad Proxy Revote At Trial
- Arnold & Porter Adds FCA, Health Care Fraud Pro
- CMS Revises National Payment Policy For Drugs, Devices
- Novartis Seeks To Stop Hospira From Selling Zometa Generic
- Ambry Hits Myriad With Antitrust Claim In Gene Test IP Row
- Merck Investors Rip Fee Requests In $688M Vytorin Deal
- Ex-InterMune CEO Urges Justices To Review Fraud Conviction
- What May Come Of CMS' Proposed Device Regulations
- GTCR Commits Up To $200M To Specialty Pharma Venture
- Kelley Drye Lures Pharma IP Pro From Edwards Wildman
- Warner Chilcott, Mylan Deal OK'd In Birth Control IP Row
- $200M Cardinal, Owens & Minor Antitrust Suit Trimmed
- 6th Circ. OKs Forfeiture Order In Fen-Phen Attys Suit
- McDermott Ducks Health IT Client's IP Theft Suit
- Warner Chilcott Says FCA Kickback Suit Is Too Vague
- Pfizer Targets Wockhardt In Generic Toviaz Suit
- Ex-SAC Trader Says Criminal Docs Off-Limits In Class Suit
- In Myriad, Did Supreme Court Confuse Its Own Precedent?
- Stay Tuned For More Developments In GINA
- Enzo, ABI Lose New Trial Bids After $49M DNA Patent Verdict
- Takeda Ruling Could Limit FCA Enforcement, 1st Circ. Hears
- Preemption May Yet Doom State-Law Reglan Claims
- Actelion Forks Over $250M For Pa. Drugmaker
- High Court's Sorrell Ruling Yet To Transform Drug Marketing
- FDA Unveils User Fee Hikes To Fund Review Of Drugs, Devices
- India Revokes GSK Breast Cancer Drug Patent
- Baxter Asks Fed. Circ. To Rethink Nixing $23M Patent Award
- House Votes To Give Congress Power Over Costly Regulations
- The Reappearance Of Ticking Fees In Delayed Closings
- Kilpatrick Townsend Grows In Atlanta With Arnall Golden Pros
- What HRSA's New Rule Means For Hospitals And Pharma Cos.
- Drugmaker UCB Sues Rival Sun Over Planned Vimpat Generic
- Becton Dickinson Pays $22M To Settle Syringe Antitrust Suits
- J&J Fined In Landmark Chinese Antitrust Loss
- Walgreen Shareholders Sue Over $80M DEA Payout
- Nova Yanks 62M Diabetes Test Strips Over False Readings
- FDA Links Acetaminophen To Fatal Skin Disease
- Med School Slaps AstraZeneca With Crestor Patent Suit
- 8th Circ. Says Petco Heater Not Covered In Medtronic Fire Suit
- Genzyme Lied About Plant Contamination, 1st Circ. Told
- Sen. Slams Walgreen After Employee Trumpets 340B Profits
- Putting Daubert In Proper Perspective
- Rainmaker Q&A: Crowe & Dunlevy's Karen Rieger